Cargando…
Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker
BACKGROUND: Biomarkers for accurate diagnosis of early hepatocellular carcinoma (HCC) are limited in number and clinical validation. We applied SELDI-TOF-MS ProteinChip technology to identify serum profile for distinguishing HCC and liver cirrhosis (LC) and to compare the accuracy of SELDI-TOF-MS pr...
Autores principales: | Chen, Lei, Ho, David W. Y., Lee, Nikki P. Y., Sun, Stella, Lam, Brian, Wong, Kwong-Fai, Yi, Xin, Lau, George K., Ng, Eddy W. Y., Poon, Terence C. W., Lai, Paul B. S., Cai, Zongwei, Peng, Jirun, Leng, Xisheng, Poon, Ronnie T. P., Luk, John M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924503/ https://www.ncbi.nlm.nih.gov/pubmed/20354800 http://dx.doi.org/10.1245/s10434-010-1038-8 |
Ejemplares similares
-
SELDI-TOF mass spectrometry of High-Density Lipoprotein
por: Levels, Johannes HM, et al.
Publicado: (2007) -
The Application of SELDI-TOF-MS in Clinical Diagnosis of Cancers
por: Liu, Chibo
Publicado: (2011) -
Novel approaches to smoothing and comparing SELDI TOF spectra
por: Meleth, Sreelatha, et al.
Publicado: (2007) -
SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma
por: Huang, Yuan-Jiao, et al.
Publicado: (2009) -
Research progress in SELDI-TOF MS and its clinical applications
por: CHO, William Chi-Shing
Publicado: (2006)